Published in Electrophoresis on August 01, 1998
Correspondence analysis applied to microarray data. Proc Natl Acad Sci U S A (2001) 3.19
Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation (1999) 3.44
Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation (2001) 3.25
CC chemokine receptor 5 and renal-transplant survival. Lancet (2001) 2.82
Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation (2000) 2.49
[Anticoagulation and thrombophilia in pregnancy]. Internist (Berl) (2008) 2.06
Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation (2004) 2.04
Association of maternal G protein beta3 subunit 825T allele with low birthweight. Lancet (2000) 1.94
Myocardial catecholamine content after heart transplantation. Circulation (1990) 1.69
Bradykinin B2BKR receptor polymorphism and left-ventricular growth response. Lancet (2001) 1.67
An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis. Gastroenterology (2000) 1.60
Total occlusion trial with angioplasty by using laser guidewire. The TOTAL trial. Eur Heart J (2000) 1.54
Intracellular energetic units in red muscle cells. Biochem J (2001) 1.53
Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase. J Hypertens (2000) 1.49
The immediate and long-term effect of optimal balloon angioplasty on the absolute coronary blood flow velocity reserve. A subanalysis of the DEBATE study. Doppler Endpoints Balloon Angioplasty Trial Europe. Eur Heart J (2001) 1.42
[Long-term outcome after coronary emergency intervention]. Dtsch Med Wochenschr (2000) 1.38
Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study. Circulation (1998) 1.37
Functional cardiac MR imaging with steady-state free precession (SSFP) significantly improves endocardial border delineation without contrast agents. J Magn Reson Imaging (2001) 1.37
Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytes. Hypertension (2001) 1.32
Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy. Clin Genet (2003) 1.28
Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy. J Am Coll Cardiol (2001) 1.24
Investigation of coronary venous anatomy by retrograde venography in patients with malignant ventricular tachycardia. Circulation (2001) 1.22
Assessment of diffuse coronary artery disease by quantitative analysis of coronary morphology based upon 3-D reconstruction from biplane angiograms. IEEE Trans Med Imaging (1995) 1.20
PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells. J Cardiovasc Pharmacol (1999) 1.15
Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation (1997) 1.15
TNFalpha induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2. Atherosclerosis (2001) 1.14
Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension (1997) 1.14
Transvenous biventricular defibrillation halves energy requirements in patients. Circulation (2001) 1.12
The apoptotic regulatory protein ARC (apoptosis repressor with caspase recruitment domain) prevents oxidant stress-mediated cell death by preserving mitochondrial function. J Biol Chem (2001) 1.12
Impact of maternal body mass index on neonatal outcome. Eur J Med Res (2009) 1.12
Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes. Eur J Pharmacol (2000) 1.12
Should stimulation site be tailored in the individual heart failure patient? Am J Cardiol (2000) 1.11
Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT). Eur Heart J (1999) 1.10
[Policy paper to the cardiac re-sychronization therapy]. Z Kardiol (2003) 1.09
Comparison of magnetic resonance real-time imaging of left ventricular function with conventional magnetic resonance imaging and echocardiography. Am J Cardiol (2001) 1.08
High-protein nutrition during pregnancy and lactation programs blood pressure, food efficiency, and body weight of the offspring in a sex-dependent manner. Am J Physiol Regul Integr Comp Physiol (2006) 1.08
Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart. Cardiovasc Res (2000) 1.07
Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure. Circulation (1993) 1.04
Improvement of myocardial perfusion reserve early after coronary intervention: assessment with cardiac magnetic resonance imaging. J Am Coll Cardiol (2000) 1.04
TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent. Hypertension (1999) 1.04
Coronary arterial stents: safety and artifacts during MR imaging. Radiology (2000) 1.03
Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease. J Am Coll Cardiol (2001) 1.01
Optimization of realtime adaptive navigator correction for 3D magnetic resonance coronary angiography. Magn Reson Med (1999) 1.01
L-selectin-dependent leukocyte adhesion to microvascular but not to macrovascular endothelial cells of the human coronary system. Blood (1997) 1.00
Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration. J Cardiovasc Pharmacol (2001) 0.98
Magnetic resonance real-time imaging for the evaluation of left ventricular function. J Cardiovasc Magn Reson (2000) 0.97
Validation of an accurate method for three-dimensional reconstruction and quantitative assessment of volumes, lengths and diameters of coronary vascular branches and segments from biplane angiographic projections. Int J Card Imaging (1999) 0.97
Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin. Circ Res (1997) 0.97
The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5/6 nephrectomy without affecting blood pressure. Br J Pharmacol (2007) 0.97
Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart Failure. Clin Res Cardiol (2011) 0.96
In vivo measurement of endothelium-dependent vasodilation with substance P in man. Herz (1992) 0.95
Gender-specific predictors of early mortality after coronary artery bypass graft surgery. Clin Res Cardiol (2012) 0.95
Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (1999) 0.94
Representation of amino acid sequences as two-dimensional point patterns. Electrophoresis (1997) 0.92
[Comparison of various parameters for determining an index of myocardial perfusion reserve in detecting coronary stenosis with cardiovascular magnetic resonance tomography]. Z Kardiol (2001) 0.91
Strong acceleration of murine lupus by injection of the SmD1(83-119) peptide. Arthritis Rheum (2001) 0.91
Novel mutation in the alpha-tropomyosin gene and transition from hypertrophic to hypocontractile dilated cardiomyopathy. Circulation (2000) 0.91
Genetic polymorphisms of the angiotensin II type 1 (AT1) receptor gene. Eur Heart J (1994) 0.91
Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation (1995) 0.90
Interaction of angiotensin II and nitric oxide in isolated perfused afferent arterioles of mice. J Am Soc Nephrol (2001) 0.89
Doxazosin inhibits monocyte chemotactic protein 1-directed migration of human monocytes. J Cardiovasc Pharmacol (2001) 0.89
Dobutamine stress magnetic resonance imaging for the detection of coronary artery disease in women. Heart (2009) 0.89
[Reimbursement questions for cardiology services within the scope of GOA:2. Position of the DRG and GOA Project Group]. Z Kardiol (2003) 0.88
Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Transplant (1991) 0.88
Noninvasive determination of coronary blood flow velocity with magnetic resonance imaging: comparison of breath-hold and navigator techniques with intravascular ultrasound. Magn Reson Med (1999) 0.88
Treating poststernotomy mediastinitis by transposition of the greater omentum: late angiographic findings. J Card Surg (1995) 0.88
Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients. Nephrol Dial Transplant (2000) 0.88
Isolation and characterization of macrovascular and microvascular endothelial cells from human hearts. Am J Physiol (1994) 0.87
Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions. Am J Cardiol (2001) 0.87
Changes in surface expression of platelet membrane glycoproteins and progression of heart transplant vasculopathy. Circulation (2000) 0.87
Integrins alphavbeta3 and alphavbeta5 mediate VSMC migration and are elevated during neointima formation in the rat aorta. Basic Res Cardiol (2001) 0.87
Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells. FEBS Lett (1999) 0.87
Clinical validation of new pacing-sensing configurations for atrial automatic capture verification in pacemakers. J Cardiovasc Electrophysiol (2001) 0.87
Regulation and differential expression of neutral endopeptidase 24.11 in human endothelial cells. Hypertension (1995) 0.87
ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin. Cardiovasc Res (1993) 0.86
High spatial resolution myocardial perfusion imaging during high dose dobutamine/atropine stress magnetic resonance using k-t SENSE. Int J Cardiol (2011) 0.86
Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans. J Am Coll Cardiol (2001) 0.86
Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries. J Cardiovasc Pharmacol (1992) 0.86
Doxazosin inhibits retinoblastoma protein phosphorylation and G(1)-->S transition in human coronary smooth muscle cells. Arterioscler Thromb Vasc Biol (2000) 0.86
Advantages of C2 monitoring to avoid acute rejection in pediatric heart transplant recipients. J Heart Lung Transplant (2006) 0.86
Myocardial cyclic AMP and norepinephrine content in human heart failure. Eur Heart J (1994) 0.85
Reduction in left ventricular messenger RNA for transforming growth factor beta(1) attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 Rat. Hypertension (2000) 0.85
Functional capacity and changes in the neurohormonal and cytokine status after long-term CRT in heart failure patients. Int J Cardiol (2007) 0.85
[2D and 3D parameter images for the analysis of contrast medium distribution in dynamic CT and MRI]. Radiologe (1998) 0.85
Dobutamine stress cardiovascular magnetic resonance at 3 Tesla. J Cardiovasc Magn Reson (2008) 0.85
Stress cardiovascular magnetic resonance: consensus panel report. J Cardiovasc Magn Reson (2001) 0.84
Characterization of two distinct mechanisms for induction of apoptosis in human vascular endothelial cells. Clin Chem Lab Med (1999) 0.84
Endothelial and vascular smooth muscle function after chronic treatment with cyclosporin A. J Cardiovasc Pharmacol (1993) 0.84
Characterization of polymorphisms in the promoter of the human angiotensin II subtype 1 (AT1) receptor gene. Ann Hum Genet (1999) 0.84